IVD Development Streamline your IVD development and business

HalioDx provides professional framework

for IVD assay development with diagnostics companies,

for CTA and CDX with pharma companies

Our capabilities cover development, manufacturing, life cycle management, regulatory and marketing support and commercialization.

Pharma Services

Thanks to its strong expertise and its compliant capabilities and processes, HalioDx successfully develops CDx tests eligible for a co-registration with the FDA and cover the whole drug development process with strong responsibilities :

  • Biomarker discovery & Design Concept
  • Assay Development (CTA)
  • Proof of Concept
  • Assay Validation
  • Clinical trial
  • PMA submission
  • Post Launch

Key features

  • Project core team including IVD experts to match customer requests and needs
  • A mature and efficient Design Control process (ISO 13485, ISO 9001, 21 CFR part 820)
  • An International regulatory expertise and track record (CLIA, CE Mark, FDA 510(k) de novo and PMA, MLHW, CFDA)
  • A wide range of technologies (IHC, Digital Pathology, QPCR, NGS)
Want to learn more on IVD Development ? Contact us



HalioDx newsletter subscription

Join our newsletter and be the first to get notified on new updates.

× Hide this popup.